BDR Gefitinib IP Tablets Details:
Brand Name: G-NIB
Contents: Gefitinib 250 mg
Strength: 250 mg
Manufactured by: BDR Pharma
Packing: Pack of 30 tablets
WHAT IS G-NIB GEFITINIB?
Gefitinib is a type of drug called a tyrosine kinase inhibitor (TKI), also known as a cancer growth inhibitor. Kinases are proteins in the body that regulate how the cells grow and divide. Gefitinib blocks (inhibits) the protein from sending signals to the cancer cells that make them grow and divide.
Gefitinib is used to treat some people with non-small cell lung cancer (NSCLC). It only works for cancers that have an abnormal form of a protein called epidermal growth factor receptor (EGFR). Tests are done on the cancer cells from a lung biopsy or previous surgery to check the level of EGFR.
POSSIBLE SIDE EFFECTS OF GEFITINIB:
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Acne; diarrhea; dry skin; loss of appetite; mouth ulcers; nausea; unusual weakness; vision problems; vomiting; weight loss.
Seek medical attention right away if any of these severe side effects occur:
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the eyelids, mouth, face, lips, or tongue); cough; dark urine; dizziness; eye irritation or pain; extreme fatigue; fever; persistent diarrhea; stomach pain; swelling of the ankles or feet; yellowing of the skin or eyes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.
PROPER STORAGE OF G-NIB GEFITINIB:
Store gefitinib at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep gefitinib out of the reach of children and away from pets.
中国北京-全球领先的制药公司阿斯利康宣布，抗癌新药易瑞沙（吉非替尼）经国家食品药品监督管理局批准正式在中国上市，用于治疗既往接受过化学治疗的局部晚期或转移性非小细胞肺癌。易瑞沙 是癌症治疗领域的一个新突破，他是世界上第一个表皮生长因子受体酪氨酸激酶抑制剂，其作用机制不同于细胞毒性药物。易瑞沙 在中国的上市将改变传统的治疗手段，为中国的既往化学治疗失败的局部晚期过转移性非小细胞肺癌患者及其家人带来新希望
G NIB Gefitinib Tablets
- Product Code: geftinat
- Prescription Required